发明名称 NOVEL DOSING REGIMENS OF CELGOSIVIR FOR THE TREATMENT OF DENGUE.
摘要 Methods of treating a dengue virus (DENV) infection in a human subject, comprising administering to the human subject a compound of Formula (I), or pharmaceutical composition comprising a compound of Formula (I):A compound of Formula (I) can be administered within onset of fever to 72 hours of fever onset due to dengue infection and then every 6 to12 hours until there is an improvement in the infection or between from about 1 day to about 10 days. The methods of the invention can be used to treat primary and secondary DENV1-4 viral infections.
申请公布号 MX2015013115(A) 申请公布日期 2016.06.21
申请号 MX20150013115 申请日期 2014.03.14
申请人 60° PHARMACEUTICALS LLC 发明人 SUBHASH VASUDEVAN;CYNTHIA SUNG;ABHAY RATHORE;SATORU WATANABE;JENNY LOW;ENG EONG OOI;GEOFFREY S. DOW;GLYNN MORRISH;MARK REID
分类号 A61P31/14 主分类号 A61P31/14
代理机构 代理人
主权项
地址